BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9218624)

  • 21. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection.
    Hoffmann RM; Diepolder HM; Zachoval R; Zwiebel FM; Jung MC; Scholz S; Nitschko H; Riethmüller G; Pape GR
    Hepatology; 1995 Mar; 21(3):632-8. PubMed ID: 7875660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease.
    Baker C; Chang L; Elsegood KA; Bishop AJ; Gannon DH; Narendran P; Leech NJ; Dayan CM
    Clin Exp Immunol; 2007 Mar; 147(3):472-82. PubMed ID: 17302896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8.
    Hoshida Y; Kato N; Yoshida H; Wang Y; Tanaka M; Goto T; Otsuka M; Taniguchi H; Moriyama M; Imazeki F; Yokosuka O; Kawabe T; Shiratori Y; Omata M
    J Infect Dis; 2005 Jul; 192(2):266-75. PubMed ID: 15962221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic and circulating HLA class II-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.
    Penna A; Missale G; Lamonaca V; Pilli M; Mori C; Zanelli P; Cavalli A; Elia G; Ferrari C
    Hepatology; 2002 May; 35(5):1225-36. PubMed ID: 11981773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.
    Lasarte JJ; García-Granero M; López A; Casares N; García N; Civeira MP; Borrás-Cuesta F; Prieto J
    Hepatology; 1998 Sep; 28(3):815-22. PubMed ID: 9731578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
    Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
    Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased frequency of IFN-gamma-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C.
    Murata M; Nabeshima S; Maeda N; Nakashima H; Kashiwagi S; Hayashi J
    J Med Virol; 2002 Jun; 67(2):162-70. PubMed ID: 11992577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.
    Ahlenstiel G; Woitas RP; Iwan A; Nattermann J; Feldmann G; Rockstroh JK; Oldenburg J; Kupfer B; Sauerbruch T; Spengler U
    Immunol Invest; 2009; 38(1):1-13. PubMed ID: 19172482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-12 activates IFN-gamma production through the preferential activation of CD30+ T cells.
    Alzona M; Jäck HM; Fisher RI; Ellis TM
    J Immunol; 1995 Jan; 154(1):9-16. PubMed ID: 7995963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cells.
    Isaguliants MG; Petrakova NV; Kashuba EV; Suzdaltzeva YG; Belikov SV; Mokhonov VV; Prilipov AG; Matskova L; Smirnova IS; Jolivet-Reynaud C; Nordenfelt E
    Vaccine; 2004 Apr; 22(13-14):1656-65. PubMed ID: 15068848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.
    Thammanichanond D; Moneer S; Yotnda P; Aitken C; Earnest-Silveira L; Jackson D; Hellard M; McCluskey J; Torresi J; Bharadwaj M
    Clin Immunol; 2008 Sep; 128(3):329-39. PubMed ID: 18524682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.
    Kita H; Moriyama T; Kaneko T; Harase I; Nomura M; Miura H; Nakamura I; Yazaki Y; Imawari M
    Hepatology; 1993 Nov; 18(5):1039-44. PubMed ID: 7693568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
    Schirren CA; Jung MC; Gerlach JT; Worzfeld T; Baretton G; Mamin M; Hubert Gruener N; Houghton M; Pape GR
    Hepatology; 2000 Sep; 32(3):597-603. PubMed ID: 10960455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors.
    Scognamiglio P; Accapezzato D; Casciaro MA; Cacciani A; Artini M; Bruno G; Chircu ML; Sidney J; Southwood S; Abrignani S; Sette A; Barnaba V
    J Immunol; 1999 Jun; 162(11):6681-9. PubMed ID: 10352286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection.
    Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
    Hepatogastroenterology; 2003; 50(49):201-6. PubMed ID: 12630023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.